A detailed history of Hrt Financial LP transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 38,721 shares of TXG stock, worth $568,037. This represents 0.0% of its overall portfolio holdings.

Number of Shares
38,721
Holding current value
$568,037
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$15.71 - $23.49 $608,306 - $909,556
38,721 New
38,721 $874,000
Q4 2023

Feb 09, 2024

BUY
$34.32 - $57.55 $1.37 Million - $2.3 Million
40,050 New
40,050 $2.24 Million
Q2 2023

Aug 11, 2023

SELL
$50.96 - $58.72 $2.02 Million - $2.33 Million
-39,723 Reduced 50.99%
38,178 $2.13 Million
Q1 2023

May 12, 2023

BUY
$35.33 - $55.79 $2.53 Million - $3.99 Million
71,590 Added 1134.37%
77,901 $4.35 Million
Q4 2022

Feb 10, 2023

BUY
$24.4 - $41.3 $153,988 - $260,644
6,311 New
6,311 $229,000

Others Institutions Holding TXG

About 10x Genomics, Inc.


  • Ticker TXG
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 95,046,400
  • Market Cap $1.39B
  • Description
  • 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...
More about TXG
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.